SymphoRNA is developing next generation RNA therapeutics using a polysaccharide based delivery platform that can deliver multiple RNAs in combination rather than focusing on a single pathway. This approach has the potential to treat diseases driven by several biological mechanisms simultaneously, expanding the reach of RNA therapeutics into areas where single-target strategies have struggled.